Unknown

Dataset Information

Concomitant Sjogren's Syndrome Was Not Associated with a Poorer Response or Outcomes in Ursodeoxycholic Acid-Treated Patients with Primary Biliary Cholangitis.


ABSTRACT: Aim:Patients with primary biliary cholangitis (PBC) have at least 60% probability of having an autoimmune extrahepatic condition, with the most common being Sjögren's syndrome (SS). The impacts of SS on the response and outcomes in ursodeoxycholic acid (UDCA)-treated patients with PBC, however, remain unclear. The aim of this study was to document the biochemical responses and clinical outcomes of UDCA-treated patients with concomitant SS and to compare the findings to those of patients with PBC alone. Methods:Data from consecutive patients with PBC who visited West China Hospital affiliated with Sichuan University between October 2013 and October 2017 were reviewed retrospectively. Results:The study populations consisted of 226 patients with PBC alone and 56 with PBC/SS. The median ages,

SUBMITTER: Ni P 

PROVIDER: S-EPMC6582895 | biostudies-literature | 2019

REPOSITORIES: biostudies-literature